- Home
- Â /Â ESSA Pharma
ESSA Pharma
Stock Price
$5.3
2024-08-26
Market Capitalization
$233.4 M
2024-08-26
ESSA Pharma Summary
Company Summary
- Overview
- ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. It offers anitens that block a target on the androgen receptor (AR), the N-terminal domain.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Vancouver, CA | view all locations
- Website
- https://www.essapharma.com/
- Cybersecurity rating
Table of Contents
Key People
David R. Parkinson, President, Chief Executive Officer & Director
Peter Virsik, Chief Operating Officer, Executive Vice President
Scott Requadt, Director
LocationsView all
3 locations detected
Vancouver, BCÂ HQ
Canada
999 W Broadway Suite: 720
Houston, TX
United States
700 Milam St #1300
South San Francisco, CA
United States
400 Oyster Point Blvd #520
ESSA Pharma Financials
Summary Financials
- Net income (Q3, 2024)
- ($7.2M)
- Cash (Q3, 2024)
- $86.0M
- Enterprise value
- $162.4M